Overview

• Robert Califf, the outgoing FDA Commissioner, expressed concerns about the direction of the agency under the new Trump administration.
• Trump has promised Robert F. Kennedy Jr., a known vaccine skeptic, a significant role in shaping public health policy.
• Califf highlighted the uncertainty and potential staff turnover at the FDA due to anticipated policy changes.
• Kennedy's controversial views on vaccines and health policy raise alarms about the future of evidence-based decision-making.
• Despite the challenges, Califf urged faith in the dedication and expertise of the FDA's workforce.